Ian Rourke

Tel: +61 3 8618 4109


  • Melbourne

Ian Rourke is a partner in our Melbourne biotechnology team.

He prepares and prosecutes patent applications internationally, evaluates the external patent landscape and intellectual property positions of competitors and conducts complex patent invalidity, infringement, due diligence and freedom-to-operate analyses. Awarded the title Most Client Focused IP Specialist at the 2017 Client Choice Awards, and a finalist in 2020, Ian has a substantial Australian client base including universities, research institutes, listed companies, and start-up companies. He was recognised in the IAM Global Leaders list for both 2023 and 2024 and has been consistently endorsed on the IAM Prosecution recommended list each year since 2018, achieving a 'Highly Recommended' status in both 2022 and 2023.


Technical Group:

Read Ian's full bio


  • Company Directors Course, Australian Institute of Company Directors
  • Diploma of Intellectual Property Practice, Institute of Patent & Trade Mark Attorneys (IPTA)
  • PhD in Molecular Biology, Australian National University
  • Bachelor of Science (Hons) in Agriculture, Biochemistry and Molecular Biology, University of New England

Industry Expertise

  • Gene therapy (including gene editing, gene silencing, siRNA, antisense, viral based delivery)
  • Therapeutics (including antibodies and other protein-based therapies, cell-based therapies, drug repurposing)
  • Vaccines
  • Diagnostics (including bioinformatics, cancer biomarkers and microorganism detection systems)
  • Plant Molecular Biology (including transgenic plants)

Professional Affiliations

  • Fellow - The Institute of Patent and Trade Mark Attorneys of Australia (IPTA)
  • Member - Australian Institute of Company Directors
  • Member - AusBiotech
  • Member - Intellectual Property Society of Australia and New Zealand (IPSANZ)